June 16, 2021
Advance Online

Advance Online
FDA Approves Cosentyx for Pediatric Patients
The FDA has approved the use of Cosentyx in patients 6 years old and older who are candidates for systemic therapy or phototherapy.
The FDA has approved the use of Cosentyx in patients 6 years old and older who are candidates for systemic therapy or phototherapy.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.